PAD 112 (Moexipril 15 mg)

Pill imprint PAD 112 has been identified as Moexipril hydrochloride 15 mg.

Moexipril is used in the treatment of high blood pressure; left ventricular dysfunction; heart failure; heart attack; diabetic kidney disease and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Moexipril 15 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for PAD 112

Moexipril  hydrochloride 15 mg PAD 112
Moexipril hydrochloride
Imprint:
PAD 112
Strength:
15 mg
Color:
Beige
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Angiotensin converting enzyme inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0112
Inactive Ingredients:
lactose monohydrate
crospovidone
magnesium oxide
povidone
silicon dioxide
magnesium stearate
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5916 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)